Long-term clinical course and outcome in patients with primary Sjögren syndrome-associated interstitial lung disease
Abstract Interstitial lung disease (ILD) is the most common lung manifestation in patients with Sjögren syndrome (SJS) and is associated with poor outcomes. This study aimed to investigate the long-term clinical course and prognostic factors in patients with SJS-ILD. Clinical data and high-resolutio...
Guardado en:
Autores principales: | Yun Jae Kim, Jooae Choe, Ho Jeong Kim, Jin Woo Song |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ba4f33c0695a495788d04471b2377d4a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndrome
por: Giulia Klinowski, et al.
Publicado: (2021) -
Progressive fibrosing interstitial lung disease: prevalence and clinical outcome
por: Byoung Soo Kwon, et al.
Publicado: (2021) -
NEUROLOGICAL MANIFESTATIONS OF PRIMARY SJOGREN’S SYNDROME (PSS)
por: Waseem Raja, et al.
Publicado: (2018) -
Clinical influences of anticentromere antibody on primary Sjögren’s syndrome in a prospective Korean cohort
por: Youngjae Park, et al.
Publicado: (2021) -
Primary Sjogren syndrome increases the risk of bisphosphonate-related osteonecrosis of the jaw
por: Pei-I Kuo, et al.
Publicado: (2021)